Cleared Traditional

K946238 - SYMBIOSIS GASTROINTESTINAL BIOPSY FORCEPS

K946238 is an FDA 510(k) clearance for SYMBIOSIS GASTROINTESTINAL BIOPSY FORCEPS, manufactured by Symbiosis Corp.. The device is a Class 1 Gastroenterology & Urology device with product code FCL cleared through the Traditional 510(k) pathway after a 29-day FDA review.

Download Printable Device Report (PDF) Official FDA 510(k) Summary (PDF)
Optimized for regulatory review, auditing and printing
Jan 1995
Decision
29d
Days
Class 1
Risk

K946238 is an FDA 510(k) clearance for the SYMBIOSIS GASTROINTESTINAL BIOPSY FORCEPS. Classified as Forceps, Biopsy, Non-electric (product code FCL), Class I - General Controls.

Submitted by Symbiosis Corp. (Miami, US). The FDA issued a Cleared decision on January 20, 1995 after a review of 29 days - a notably fast clearance cycle.

This device falls under the Gastroenterology & Urology FDA review panel, regulated under 21 CFR 876.1075 - the FDA gastroenterology and urology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

FDA 510(k) Submission Details - K946238

510(k) Number K946238 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received December 22, 1994
Decision Date January 20, 1995
Days to Decision 29 days
Submission Type Traditional
Review Panel Gastroenterology & Urology (GU)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
102d faster than avg
Panel avg: 131d · This submission: 29d
Pathway characteristics
Predicate-based equivalence.

FCL Device Classification - Class 1, General Controls

Product Code FCL Forceps, Biopsy, Non-electric
Device Class Class 1 - General Controls
CFR Regulation 21 CFR 876.1075
What this classification means

Class I devices are subject to general controls only and most are exempt from 510(k) premarket notification. They represent the lowest regulatory burden in the FDA device framework.

Regulatory Peers - FCL Forceps, Biopsy, Non-electric

All 38
Devices cleared under the same product code (FCL) and FDA review panel - the closest regulatory comparables to K946238.
RITE-BITE BIOPSY FORCEPS
K951048 · Mill-Rose Laboratory · Mar 1995
MODULAR BIOPSY FORCEP
K946360 · Cox Medical Ent., Inc. · Mar 1995
DIENER RETRIEVAL DEVICES
K950559 · Mill-Rose Laboratory · Feb 1995
LSVP INTERNATIONAL BIOPSY FORCEPS
K944770 · Lsvp Intl., Inc. · Oct 1994
EMC FLEXIBLE BIOPSY FORCEPS
K941816 · Enterprise Medical Corp. · Jul 1994
GIP/MEDI-GLOBE BIOPSY FORCEPS
K941359 · Medi-Globe Corp. · Jul 1994